Updated Drug Therapy Guidelines Available Online - June 2022
Updated Drug Therapy Guidelines – Legacy Systems
To: All MD/DO
Contracts affected: Commercial only
Twenty-nine (29) drug therapy guidelines were added or updated recently by a committee of local physicians, other prescribers, and pharmacists.
Updated policies for the following drug therapies are effective July 1, 2022 and are currently posted on our website:
- Cimzia
- Rinvoq
- Simponi
- Taltz
Additional new and updated policies will be posted on our website by July 1, 2022 and will be effective August 1.
Please refer to these new and updated guidelines when discussing treatment options with your legacy Highmark Blue Shield of Northeastern New York patients.
If you do not have access to the internet, you may request a paper copy by calling Provider Service at 1-800-444-4552 or 518-220-5620.
Updated Drug Therapy Guidelines – Highmark Systems
Highmark’s Pharmacy and Therapeutics (P&T) committee recently reviewed and approved multiple drug policy guidelines. New and updated policies will be available through the Provider Resource Center.
Please review these policies when discussing treatment options for your patients on Highmark’s systems.
Recent Articles
Working with Us
Additional Resources
We want to hear from you! Have a topic request for the next Blue Bulletin? Email us
Stay in Touch! Sign up to receive emails for provider news and information